期刊文献+

帕金森病患者多节点运动监测可穿戴设备 被引量:9

Wearable Devices for Movement Monitoring of Patients with Parkinson's Disease
原文传递
导出
摘要 运动症状定量评估是帕金森病临床精准诊疗和长期管理的关键,帕金森病定量评估技术难点在于实现多信息、微负荷、长时程、大活动范围的运动监测。本文研制了一套用于帕金森病定量评估的多节点运动信息监测可穿戴设备,采用五个微型传感器节点实现上、下肢和腰部的多身体部位运动信息同步监测;同时基于微功耗Wi-Fi技术构建大范围无线传感网,实现多传感器数据远距离无线传输;并且研发了多线程同步传输的长时程数据采集软件。传感器节点体积为39mm×33mm×16mm,重量18g,工作时长12h,无线数据传输距离为45m。经帕金森病患者和正常人群测试,设备可在医院等复杂场景下实现可靠运动监测。 Quantitative assessment of the symptoms of Parkinson's disease is the key for precise diagnosis and treatment and essential for long term management over years. The challenges of quantitative assessment on Parkinson's disease are rich information, ultra-low load, long term and large range monitoring in free-moving condition. In this paper, we developed wearable devices with multiple sensors to monitor and quantify the movement symptoms of Parkinson's disease. Five wearable sensors were used to record motion signals from bilateral forearms, legs and waist. A local area network based on low power Wi-Fi technology was built for long distance wireless data transmission. A software was developed for signal recording and analyzing. The size of each sensor was 39 mm×33 mm×16 mm and the weight was 18g. The sensors were rechargeable and able to run 12 hours. The wireless transmission radius is about 45 m. The wearable devices were tested in patients and normal subjects. The devices were reliable and accurate for movement monitoring in hospital.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2016年第6期1183-1190,共8页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(81471745) 江苏省科技计划资助项目(BE2015648) 苏州市神经工程技术重点实验室资助项目(SZS01414) 苏州市医疗器械与新医药专项重点资助项目(ZXY201425)
关键词 微型 低功耗 无线 定量 miniature low power wireless quantitative
  • 相关文献

参考文献3

二级参考文献34

  • 1王文磊,徐汀荣.多线程编程技术实现经典进程同步问题[J].计算机技术与发展,2006,16(3):110-112. 被引量:7
  • 2熊邦毛,熊叶明,张再萍.用多线程技术解决单线程冲突问题[J].计算机与数字工程,2007,35(1):115-118. 被引量:5
  • 3Gordon AM, Reilmann R. Getting a grasp on research: does treatment taint testing of parkinsonian patients[J]. Brain, 1999, 122(Pt 8) : 1597-1598.
  • 4Vingerhoets FJ, Schulzer M, Calne DB, et al. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion [J]. AnnNeurol, 1997,41(1): 58-64.
  • 5Bemheimer H, Birkmayer W, Homykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington[J]. Neurol Sci, 1973,20(4) :415-455.
  • 6Rinne UK, Sonninen V. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease[J]. Neu- rology, 1972, 22(1):62-67.
  • 7Postuma RB, Lang AE, Massicotte-Marquez J, et al. Potential early markers of Parkinson disease in idiopathic REM sleep be- havior disorder[J]. Neurology, 2006,66(6) :845-851.
  • 8Nutt JG, Lea ES, Van HL, et al. Determinants of tapping speed in normal control subjects and subjects with Parkinson's disease: differing effects of brief and continued practice [J]. Mov Disord, 2000,15(5) :843-849.
  • 9Pal PK, Lee CS, Samii A, et al. Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [J]. Parkinsonism and Related Disorders, 2001,7(4) :305-309.
  • 10Desrosiers J, Hebert R, Bravo G, et al. The Purdue Pegboard Test: normative data for people aged 60 and over[J]. Disabil Rehabil, 1995,17(5) :217-224.

共引文献18

同被引文献36

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部